Post-diagnostic Dietary Changes Among Men with Prostate Cancer Beneficial
the Cancer Therapy Advisor take:
General advice about diet from a qualified health professional may provide men diagnosed with prostate cancer with a focus for action and a means of trying to regain control, according to an article published online in the journal European Journal of Cancer Care.
In this study, eight men from the UK diagnosed with prostate cancer within the last 5 years reported changes they made to their diet post-diagnosis.
Two major themes were observed from the thematic analysis of the data: the first was about the perceived nature and importance of dietary change and the second about the perceived determinants of dietary change. The second theme focused on internal dimensions (eg agency) and external dimensions (eg, perceived role of relationship with health professionals, availability of dietary information with credibility, and family influences).
Furthermore, results showed family influences and context were linked to enabling men into implementing dietary changes.
General advice about diet from a qualified health professional may provide men diagnosed with prostate cancer with a focus for action.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Plastics and Cancer
- Cabozantinib Shows Promising Activity in Osteosarcoma and Ewing Sarcoma
- Real-World Study Shows High Response Rates to T-VEC in Early Metastatic Melanoma
- Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection
- Are Next-Gen Antibody-Drug Conjugates a Path Forward for Non-Hodgkin Lymphoma and Myeloma?
- First-Line Alectinib Effective in Asian Patients With ALK-Positive Advanced NSCLC
- Pembrolizumab Alone or With Chemotherapy Prolongs OS in Recurrent/Metastatic HNSCC
- Pembrolizumab With Dabrafenib and Trametinib Shows Efficacy, But High TRAEs, in Melanoma
- Assays May Help Researchers Discover Factors Underlying Immunotherapy Response
- Atezolizumab Combo Improved PFS, OS in Stage IV Non-Small Cell Lung Cancer